Latest News


Researchers identify the best way to ease chronic pain.

With large numbers of people across the community looking for effective and lasting ways to treat pain, our researchers at the Kolling Institute are driving nationally significant projects to reduce a reliance on opioid medication and promote proven alternative options. The research by our team from the Pain Management Research Centre follows the latest figures which indicate around 20 p.....
Read more

Category: Neuroscience and Pain Research, New Treatment, Research Excellence

Researchers to join leading cancer care centres in exciting new trial.

Researchers from the Kolling Institute and Royal North Shore Hospital will help drive a new project investigating a revolutionary approach to care for those with neuroendocrine tumours. Cancer specialists Professor Nick Pavlakis and Dr David Chan will join the AUS-NET trial after a funding announcement by Health Minister Greg Hunt. The study will assess whether a new patient-specific car.....
Read more

Category: Funding support, Research Excellence

Research shows your age and sex influence the impact of medications .

A new study by researchers at the Kolling Institute will directly guide the use of medications by older Australians after it identified the profound adverse effects of taking multiple medications. The study follows the latest figures which show around 50 per cent of Australians over 75 years take five or more medications every day to treat multiple chronic illnesses. The trend is leading.....
Read more

Category: Research Excellence

Exciting study to investigate new treatment for acute myeloid leukaemia.

The Cancer Council NSW today announced funding for a new stem cell team at the Kolling Institute to examine a revolutionary approach to treatment for those with acute myeloid leukaemia. This aggressive form of blood cancer has a tragically poor survival rate, and while we have seen tremendous progress for many other types of cancer in recent years, there have been very limited improvemen.....
Read more

Category: Funding support, Research Excellence

New cutting-edge technology coming to the Kolling.

The Kolling is set to be one of the first institutes in New South Wales to introduce new world-leading technology, boosting our cancer and neuroscience research capabilities. The Digital Spatial Profiling System has been made possible following a $535,000 grant from the Australian Research Council LIEF scheme. The project is being co-funded by the University of Sydney with a $250,000 con.....
Read more

Category: Research Excellence, World-leading technology

Program supporting injured workers wins top award.

Kolling researchers have taken out a highly-competitive, national award for an innovative program helping people get back to work after injury. Professor Michael Nicholas and Dr Manasi Mittinty from the Pain Management Research Centre were part of a team which received a National Safety Award of Excellence for their initiative targeting injured workers. The program was trialled with staf.....
Read more

Category: Awards, Research Excellence

Kolling researcher to join prestigious Harvard Medical School program.

Congratulations to Kolling Institute researcher Dr Manasi Mittinty who has been selected for the Advanced Global Clinical Scholar Research training at Harvard Medical School. Dr Mittinty is a medical trained researcher with the Pain Management and Research Centre and a University of Sydney lecturer. She has a keen interest in translation research and the connections between musculoskelet.....
Read more

Category: Musculoskeletal Research, Neuroscience and Pain Research

Researchers confirm extreme heat increases the risk of premature births.

Researchers have found that women are more likely to have a preterm birth when exposed to extreme heat and those with pre-existing conditions may have an even higher risk. Preterm or premature birth, when a baby is born before 37 weeks of pregnancy, is the leading cause of infant death worldwide and many children born early deal with ongoing health problems for the remainder of their liv.....
Read more

Category: Research Excellence

Study confirms deadly risk of COVID-19 for those with heart failure .

The largest study of its kind in Australia has found patients with a history of heart failure are three times more likely to die from COVID-19. Launched last year at the outset of the pandemic, the AUS-COVID trial is investigating those who are most at risk from COVID-19 in Australia. To date, it has assessed hundreds of patients in 21 hospitals across the country. The study confirmed ea.....
Read more

Category: Cardiovascular and Renal Research, Research Excellence

The Kolling’s up and coming talent recognised .

Acting Executive Director Professor Jim Elliott has announced the winners of the inaugural Kolling Institute Emerging Leader Awards, saying there’s an inspiring depth of expertise throughout the institute. Professor Elliott said the new awards recognise our young leaders across our basic and translational research, and were initiated by the institute’s Workforce and Culture Enabler Commi.....
Read more

Category: Awards